1Division of Endocrinology and Metabolism, Konyang University Hospital, Konyang University College of Medicine, Daejeon, Korea.
2Division of Endocrinology and Metabolism, Jeju National University Hospital, Jeju National University College of Medicine, Jeju, Korea.
Copyright © 2012 Korean Diabetes Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Values are presented as mean±standard deviation or number (%). The four groups were defined as follows: Group 1 (basal C-peptide <1.9 ng/mL, ΔC-peptide <1.1 ng/mL), Group 2 (basal C-peptide <1.9 ng/mL, ΔC-peptide ≥1.1 ng/mL), Group 3 (basal C-peptide ≥1.9 ng/mL, ΔC-peptide <1.1 ng/mL), and Group 4 (basal C-peptide ≥1.9 ng/mL, ΔC-peptide ≥1.1 ng/mL). DM, diabetes mellitus; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; HbA1c, hemoglobin A1c; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; GFR, glomerular filtration rate; Apo, apolipoprotein; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA-β, homeostasis model assessment of β-cell function.
Values are presented as number (%). The four groups were defined as follows: Group 1 (basal C-peptide <1.9 ng/mL, ΔC-peptide <1.1 ng/mL), Group 2 (basal C-peptide <1.9 ng/mL, ΔC-peptide ≥1.1 ng/mL), Group 3 (basal C-peptide ≥1.9 ng/mL, ΔC-peptide <1.1 ng/mL), and Group 4 (basal C-peptide ≥1.9 ng/mL, ΔC-peptide ≥1.1 ng/mL). NPDR/PDR, non-proliferative/proliferative retinopathy; Micro/Overt, micro albuminuria/overt albuminuria.
Groups A, B, and C are composed of serial data (192 patients). OR, odds ratio; CI, confidence interval; DM, diabetes mellitus; HbA1c, hemoglobin A1c.
Groups A and B are composed of serial data. OR, odds ratio; CI, confidence interval; DM, diabetes mellitus.
Groups A and B are composed of serial data. OR, odds ratio; CI, confidence interval; DM, diabetes mellitus; HbA1c, hemoglobin A1c.
Groups A and B are composed of serial data. OR, odds ratio; CI, confidence interval; DM, diabetes mellitus; HbA1c, hemoglobin A1c.
DM, diabetes mellitus; HbA1c, hemoglobin A1c; SBP, systolic blood pressure; FBS, fasting blood sugar.